Functional Role of Phospholipase D in Bone Metabolism

참고문헌 (57)

1. Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)[DOI]
2. Kim BJ, "Coupling factors involved in preserving bone balance", Cell Mol Life Sci, 76, pp.1243~1253 (2019)[DOI]
3. Takayanagi H, "Osteoimmunology : Shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7, pp.292~304 (2007)[DOI]
4. Teitelbaum SL, "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)[DOI]
5. Kong YY, "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis", Nature, 397, pp.315~323 (1999)[DOI]
6. Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)[DOI]
7. -related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor, "J Exp Med", 1997, 2075~2080, https:
8. Yasuda H, "Osteoclast differentiation factor is a ligand for osteoprotegerin", osteoclastogenesis-inhibitory factor and is identical to TRANCE, Proc Natl Acad Sci U S A, pp.1998, 95[DOI]
9. 박진희, "Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation", Molecules and Cells, 40(10), pp.706~713 (2017), 한국분자세포생물학회[DOI]
10. Takayanagi H, "Induction and activation of the transcription factor NFATc1(NFAT2)integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)[DOI]
11. 김정하, "Regulation of NFATc1 in Osteoclast Differentiation", 대한골대사학회지, 21(4), pp.233~241 (2014), 대한골대사학회[DOI]
12. Feng X, "Osteoclasts : New insights", Bone Res, 1, pp.11~26 (2013)[DOI]
13. Teitelbaum SL, "The osteoclast and its unique cytoskeleton", Ann N Y Acad Sci, 1240, pp.14~17 (2011)[DOI]
14. Yoshida H, "The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene", Nature, 345, pp.442~444 (1990)[DOI]
15. Pixley FJ, "CSF-1 regulation of the wandering macrophage : Complexity in action", Trends Cell Biol, 14, pp.628~638 (2004)[DOI]
16. Brown HA, "Targeting phospholipase D in cancer, infection and neurodegenerative disorders", Nat Rev Drug Discov, 16, pp.351~367 (2017)[DOI]
17. Ghim J, "Accumulating insights into the role of phospholipase D2 in human diseases", Adv Biol Regul, 61, pp.42~46 (2016)[DOI]
18. Frohman MA, "The phospholipase D superfamily as therapeutic targets", Trends Pharmacol Sci, 36, pp.137~144 (2015)[DOI]
19. Kodaki T, "Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain", J Biol Chem, 272, pp.11408~11413 (1997)[DOI]
20. Hammond SM, "Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family", J Biol Chem, 270, pp.29640~29643 (1995)[DOI]
21. Colley WC, "Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization", Curr Biol, 7, pp.191~201 (1997)[DOI]
22. Freyberg Z, "Intracellular localization of phospholipase D1 in mammalian cells", Mol Biol Cell, 12, pp.943~955 (2001)[DOI]
23. Du G, "Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs", J Cell Biol, 162, pp.305~315 (2003)[DOI]
24. Brown FD, "Phospholipase D1 localises to secretory granules and lysosomes and is plasma-membrane translocated on cellular stimulation", Curr Biol, 8, pp.835~838 (1998)[DOI]
25. O’Luanaigh N, "Continual production of phosphatidic acid by phospholipase D is essential for antigen-stimulated membrane ruffling in cultured mast cells", Mol Biol Cell, 13, pp.3730~3746 (2002)[DOI]
26. Du G, "Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis", Mol Biol Cell, 15, pp.1024~1030 (2004)[DOI]
27. Park JB, "Phospholipase signalling networks in cancer", Nat Rev Cancer, 12, pp.782~792 (2012)[DOI]
28. Kang DW, "Functional regulation of phospholipase D expression in cancer and inflammation", J Biol Chem, 289, pp.22575~22582 (2014)[DOI]
29. Jin JK, "Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer’s disease patients", Neurosci Lett, 407, pp.263~267 (2006)[DOI]
30. Hong KW, "Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension", J Hum Hypertens, 24, pp.763~774 (2010)[DOI]
31. Bae EJ, "Phospholipase D1 regulates autophagic flux and clearance of α-synuclein aggregates", Cell Death Differ, 21, pp.1132~1141 (2014)[DOI]
32. Kim Hyun-Ju, "Phospholipase D2 controls bone homeostasis by modulating M-CSF-dependent osteoclastic cell migration and microtubule stability", Experimental and Molecular Medicine, 54, pp.1~10 (2022), 생화학분자생물학회[DOI]
33. Kang DW, "Deletion of phospholipase D1 decreases bone mass and increases fat mass via modulation of Runx2, β-catenin-osteoprotegerin, PPAR-γ and C", EBPα signaling axis, 2021, pp.1867, 166084~
34. Blackwell KA, "Prostaglandins in bone: bad cop, good cop?", Trends Endocrinol Metab, 21, pp.294~301 (2010)[DOI]
35. Imamura Y, "Mechanism of phospholipase D activation induced by prostaglandin D2 in osteoblast-like cells : function of Ca2+", calmodulin, 1995, pp.7, 45~51
36. Oiso Y, "Effect of prostaglandin E2 on phospholipase D activity in osteoblast-like MC3T3-E1 cells", J Bone Miner Res, 10, pp.1185~1190 (1995)[DOI]
37. Kozawa O, "Prostaglandin F2 alpha activates phospholipase D independently from activation of protein kinase C in osteoblast-like cells", J Cell Biochem, 55, pp.373~379 (1994)[DOI]
38. Sugiyama T, "Prostaglandin F2 alpha-stimulated phospholipase D activation in osteoblast-like MC3T3-E1 cells: involvement in sustained 1,2-diacylglycerol production", Biochem J, 298, pp.479~484 (1994)[DOI]
39. Kozawa O, "Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells", Endocrinology, 136, pp.4473~4478 (1995)[DOI]
40. Suzuki A, "Basic fibroblast growth factor stimulates phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells", J Cell Biochem, 63, pp.491~499 (1996)[DOI]
41. Carpio LC, "Activation of phospholipase D signaling pathway by epidermal growth factor in osteoblastic cells", J Bone Miner Res, 13, pp.1707~1713 (1998)[DOI]
42. Carpio LC, "Phosphatidic acid effects on cytosolic calcium and proliferation in osteoblastic cells", Prostaglandins Leukot Essent Fatty Acids, 59, pp.101~109 (1998)[DOI]
43. Singh AT, "Parathyroid hormone stimulates phosphatidylethanolamine hydrolysis by phospholipase D in osteoblastic cells", Lipids, 40, pp.1135~1140 (2005)[DOI]
44. Singh AT, "G alpha12", G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells, 2005, pp.146, 2171~2175
45. Kim MJ, "Activation of phospholipase D1 by surface roughness of titanium in MG63 osteoblast-like cell", Biomaterials, 27, pp.5502~5511 (2006)[DOI]
46. Abdallah D, "Effects of phospholipase D during cultured osteoblast mineralization and bone formation", J Cell Biochem, 120, pp.5923~5935 (2019)[DOI]
47. Bendre MS, "Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway", Cancer Res, 65, pp.11001~11009 (2005)[DOI]
48. Hsu YL, "Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis", Carcinogenesis, 31, pp.587~596 (2010)[DOI]
49. Wan Y, "PPAR-gamma regulates osteoclastogenesis in mice", Nat Med, 13, pp.1496~1503 (2007)[DOI]
50. Chen W, "C", EBPα regulates osteoclast lineage commitment, 2013, pp.110, 7294~7299
51. Han SW, "DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signalling", Cardiovasc Res, 98, pp.73~82 (2013)[DOI]
52. Munugalavadla V, "The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration", Mol Cell Biol, 28, pp.7182~7198 (2008)[DOI]
53. Destaing O, "Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein", Mol Biol Cell, 14, pp.407~416 (2003)[DOI]
54. Jurdic P, "Podosome and sealing zone : specificity of the osteoclast model", Eur J Cell Biol, 85, pp.195~202 (2006)[DOI]
55. Hong JM, "Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation", J Bone Miner Res, 26, pp.657~665 (2011)[DOI]
56. Shinohara M, "Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport", J Bone Miner Res, 27, pp.2464~2475 (2012)[DOI]
57. Matsumoto T, "Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase B-mediated microtubule stabilization", J Bone Miner Res, 28, pp.1191~1202 (2013)[DOI]

관련 논문AI추천